KR820000254B1 - Process for preparing methanobenzo(g)quinoline-3-carboxylate - Google Patents

Process for preparing methanobenzo(g)quinoline-3-carboxylate Download PDF

Info

Publication number
KR820000254B1
KR820000254B1 KR1019810003793A KR810003793A KR820000254B1 KR 820000254 B1 KR820000254 B1 KR 820000254B1 KR 1019810003793 A KR1019810003793 A KR 1019810003793A KR 810003793 A KR810003793 A KR 810003793A KR 820000254 B1 KR820000254 B1 KR 820000254B1
Authority
KR
South Korea
Prior art keywords
lower alkyl
phenyl
alkyl
alkoxy
formula
Prior art date
Application number
KR1019810003793A
Other languages
Korean (ko)
Inventor
후란시스 미친 윌리암
리차아드 루이스 토마스
Original Assignee
스터어링 드럭그 인코포레이팃드
윌리암 에이 헤이크 쥬니어
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR7800801A external-priority patent/KR820000253B1/en
Application filed by 스터어링 드럭그 인코포레이팃드, 윌리암 에이 헤이크 쥬니어 filed Critical 스터어링 드럭그 인코포레이팃드
Priority to KR1019810003793A priority Critical patent/KR820000254B1/en
Application granted granted Critical
Publication of KR820000254B1 publication Critical patent/KR820000254B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Title compds. (I; R1 = H, lower alkyl, lower alkenyl, halo-lower alkenyl, cycloalkyl; R2, R2', R2", R2"' = halogen, H, lower alkyl, hydroxy, lower alkanoyloxy, lower alkoxy nitro, amino; R3 = H, lower alkyl; R4 = H, lower alkyl, lower alkoxy-lower alkyl, hydroxy-lower alkyl; R5 = lower alkyl, lower alkylthio-lower alkyl, lower alkoxy; Alk = lower alkyl; R5" = R5"' = R5; X = halogen), useful as analgesics, were prepd. by the reaction of R"-CO-X and alkali metal salt obtained from alkali metal amide and Ib.

Description

메타노벤조(g) 퀴놀린-3-카복실레이트를 제조하는 방법Method for preparing metanobenzo (g) quinoline-3-carboxylate

본 발명은 진통제 및 진통길항제로 유용한 11(eq)-(2-아실에틸)-2, 6-메타노-3-벤즈아조신의 제조중간체 인 저급알킬 3-아실-옥타하이드로-2,5-메타노벤조[g]퀴놀린-3-카복실레이트의 제조방법에 관한 것이다.The present invention is an intermediate of the preparation of 11 (eq)-(2-acylethyl) -2, 6-methano-3-benzazosin, useful as analgesic and analgesic antagonist, lower alkyl 3-acyl-octahydro-2,5-meta It relates to a method for producing nobenzo [g] quinoline-3-carboxylate.

미국 특허 3,932, 422에는 1, 2, 3, 4, 5, 6-헥사하이드로-11(eq)-(2-아실에틸)-2, 6-메타노-3-벤즈아조신의 제조중간체로 유용한 3-아실-1, 2, 3, 4, 4a, 5, 10, 10a-옥타하이드로-2, 5-메타노 벤조[g]-퀴놀린에 대해 기술되어 있다. 그러나 가장 좋은 반응조건하에서도 상기 방법에서는 부산물로서 상당량의 2-치환된-1, 2, 3, 4, 4a, 5, 10, 10a-옥타하이드로-3, 5-에테노벤조[g]-퀴놀린이 생성되어 목적물인 2, 6-메타노-3-벤즈아조신의 수득율을 감소시킨다.U.S. Pat.Nos. 3,932,422 are useful as intermediates for the preparation of 1, 2, 3, 4, 5, 6-hexahydro-11 (eq)-(2-acylethyl) -2, 6-methano-3-benzazocin. -Acyl-1, 2, 3, 4, 4a, 5, 10, 10a-octahydro-2, 5-methano benzo [g] -quinoline. However, even under the best reaction conditions, the process yields significant amounts of 2-substituted-1, 2, 3, 4, 4a, 5, 10, 10a-octahydro-3, 5-ethenobenzo [g] -quinoline as by-products. Is produced to reduce the yield of the desired product 2, 6-methano-3-benzazosine.

본 발명은 헥사하이드로-2, 6-메타노-3-벤즈아조신의 제조중간체로서 유용한 저급알킬-1-R1-3-R5CO-4aα-R3-5α-R4-6-R"2-8-R'2-9-R"'2-1, 2, 3, 4, 4a, 5, 10, 10a-옥타하이드로-2, 5-메타노벤조[g] 퀴놀린-3-카복실레이트의 제조방식에 관한 것이다. 특히 본 발명은 다음 구조식(I)을 갖는 가치있는 중간체를 제공한다.The present invention relates to lower alkyl-1-R 1 -3-R 5 CO-4aα-R 3 -5α-R 4 -6-R "useful as intermediates for the preparation of hexahydro-2, 6-methano- 3 -benzazosine. 2 -8-R ' 2 -9-R "' 2 -1, 2, 3, 4, 4a, 5, 10, 10a-octahydro-2, 5-methanobenzo [g] quinoline-3-carboxylate It relates to a manufacturing method of. In particular, the present invention provides valuable intermediates having the following structure (I).

Figure kpo00001
Figure kpo00001

상기 구조식(I) 화합물은 저급-알킬-1-R1-3-R5CO-4aα-R3-5α-R4-6-R2"-7-R2-8-R2'-9-R"'2-1, 2, 3, 4, 4a, 5, 10, 10a-옥타하이드로-2, 5-메타노벤조[g] 퀴놀린-3-카복실레이트이며 다음 구조식(Ⅱ)인 3-R1-6(eq)-R4-7-R2"-8-R2-9-R2'-10-R2"'-11(ax)-R3-11(eq)-CH2CH2COR5-2, 6-메타노-3-벤즈아조신의 제조에 유용하다.The compound of formula (I) is lower-alkyl-1-R 1 -3-R 5 CO-4aα-R 3 -5α-R 4 -6-R 2 "-7-R 2 -8-R 2 '-9 -R "' 2 -1, 2, 3, 4, 4a, 5, 10, 10a-octahydro-2, 5-methanobenzo [g] quinoline-3-carboxylate, 3- R 1-6 (eq) -R 4-7 -R 2 "-8-R 2 -9-R 2 '-10-R 2 "' -11 (ax) -R3-11 (eq) -CH 2 CH 2 COR 5 -2, 6- meth furnace 3-benzamide azo useful in the manufacture of God.

Figure kpo00002
Figure kpo00002

상기구조식(I), (Ⅱ)에서In the above formulas (I), (II)

R1은 수소, 저급알킬, 저급알케닐, 저급아키닐, 할로-저급알케닐, 싸이클로알킬, 싸이클로알킬-저급알킬, 2-또는 3-푸릴메틸, 또는 환의 비치환 된 탄소원자에 1-3개의 메틸기로 치환된 2-또는 3-푸릴 메틸, 또는 페닐-저급알킬, 또는 페닐환에 1-2개의 할로겐(브롬, 염소, 불소를 포함), 저급알킬, 하이드록시, 저급알카노일옥시, 저급알콕시, 저급알킬메르캅토, 트리플루오로메틸, 아미노, 저급알카노일 아미노 또는 인접된 탄소에 붙은 하나의 메틸렌디옥시로 치환된 페닐-저급알킬이고 ; R2, R2', R2",R2"'는 각각 수소, 또는 그중 3개는 수소이고 4번째는 할로겐(브롬, 염소, 불소를 포함)이거나, 저급알킬, 하이드록시 저급알카노일옥시, 저급알콕시, 저급알킬메르캅토트, 리플루오로메틸, 니트로, 아미노, 저급알카노일아미노, 저급알콕시 카보닐아미노, 페닐, 또는 인접한 2개가 함께 메틸렌디옥시이고; R3는 수소 또는 저급알킬이고; R4는 수소, 저급알킬, 저급알콕시-저급알킬, 하이드록시-저급알킬, 저급알킬티오-저급알킬, 저급알킬-설피닐-저급알킬, 페닐티오-저급알킬, 페닐-설피닐-저급알킬-저급알케닐 또는 할로-저급알킬, 또는 R3와 R4가 함께 2가의 저급알킬렌, -(CH2)n-(여기서 n은 3 또는 4이다)이고 R5는 저급알킬, 저급알킬티오-저급알킬, 저급알콕시-저급알킬, 저급알콕시, 싸이클로알킬, 싸이클로알킬-저급알킬, 2-또는 3-푸릴, 2-또는 3-푸릴-(CH2)m (여기서 m은 2-4의 정수임), 또는 비치환된 환 탄소원자가 1-3개의 메틸기로 치환된 2-또는 3-푸릴이나 2-또는 3-푸릴-(CH2)m, 또는 페닐, 페닐-(CH2)m 또는 페닐환에 할로겐(브롬, 염소, 불소를 포함) 저급알킬, 하이드록시, 저급알카노일옥시, 저급알콕시, 저급알킬메르캅토, 트리플루오로메틸, 아미노, 저급알카노일아미노 또는 인접탄소원자에 붙은 하나에 메틸렌디옥시로 구성된 1-2개의 구룹으로 치환된 페닐 또는 페닐-(CH2)m 이고; AIK는 저급알킬을 나타낸다.R 1 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, halo-low alkenyl, cycloalkyl, cycloalkyl-lower alkyl, 2- or 3-furylmethyl, or 1-3 on unsubstituted carbon atoms of the ring; 2- or 3-furyl methyl substituted with 2 methyl groups, or phenyl-lower alkyl, or 1-2 halogens (including bromine, chlorine, fluorine), lower alkyl, hydroxy, lower alkanoyloxy, lower in phenyl ring Alkoxy, lower alkyl mercapto, trifluoromethyl, amino, lower alkanoyl amino or phenyl-lower alkyl substituted with one methylenedioxy attached to adjacent carbon; R 2 , R 2 ', R 2 ", R 2 "' are each hydrogen, or three of them are hydrogen and the fourth is halogen (including bromine, chlorine and fluorine), or lower alkyl, hydroxy lower alkanoyloxy , Lower alkoxy, lower alkyl mercaptote, lifluoromethyl, nitro, amino, lower alkanoylamino, lower alkoxy carbonylamino, phenyl, or two adjacent together are methylenedioxy; R 3 is hydrogen or lower alkyl; R 4 is hydrogen, lower alkyl, lower alkoxy-lower alkyl, hydroxy-lower alkyl, lower alkylthio-lower alkyl, lower alkyl-sulfinyl-lower alkyl, phenylthio-lower alkyl, phenyl-sulfinyl-lower alkyl- Lower alkenyl or halo-lower alkyl, or R 3 and R 4 together are divalent lower alkylene,-(CH 2 ) n-, where n is 3 or 4 and R 5 is lower alkyl, lower alkylthio- Lower alkyl, lower alkoxy-lower alkyl, lower alkoxy, cycloalkyl, cycloalkyl-lower alkyl, 2- or 3-furyl, 2- or 3-furyl- (CH 2 ) m, where m is an integer of 2-4 Or 2- or 3-furyl or 2- or 3-furyl- (CH 2 ) m, wherein unsubstituted ring carbon atoms are substituted with 1-3 methyl groups, or phenyl, phenyl- (CH 2 ) m or phenyl rings. Halogen (including bromine, chlorine, fluorine) lower alkyl, hydroxy, lower alkanoyloxy, lower alkoxy, lower alkyl mercapto, trifluoromethyl, amino, lower alkanoylamino or adjacent Phenyl or phenyl- (CH 2 ) m substituted with 1-2 groups of methylenedioxy to one carbon atom; AIK stands for lower alkyl.

본 명세서에서 사용된 저급알킬이나 저급알콕시란 용어는 1 내지 약 7개의 탄소수를 가진 직쇄 또는 분지쇄의 포화된 비환상기를 의미하는데 예를 들면 메틸, 에틸, 프로필, 이소프로필 부틸, 인접하지 않은 t-부틸, 메톡시, 에톡시, 프로폭시, 이소프로폭시 또는 t-부톡시이다.As used herein, the term lower alkyl or lower alkoxy refers to a straight or branched chain saturated acyclic phase having from 1 to about 7 carbon atoms, for example methyl, ethyl, propyl, isopropyl butyl, non-adjacent t -Butyl, methoxy, ethoxy, propoxy, isopropoxy or t-butoxy.

여기에서 저급알케닐, 할로-저급알케닐 및 저급알키닐 이란 용어는 1개의 2중 또는 3중 결합을 가진 3-7개의 탄소수로 된 1개의 원자단을 나타내는데 예를 들면 1-프로페닐, 2-부테닐, 4-펜테닐, 3-메틸-2-부테닐, 1-메틸-2-프로페닐, 2-메틸, 2-프로피닐, 2-프로피닐, 2-부티닐, 4-펜티닐, 2-헥시닐, 등이고 할로-저급알키닐에는 3-클로로-2-프로페닐, 3-브로모-2-프로페닐, 3, 3-디클로로-2-프로페닐, 3-브로모-2-메틸-2-프로페닐 등이 포함된다.The terms lower alkenyl, halo-lower alkenyl and lower alkynyl here refer to one atomic group of 3-7 carbon atoms having one double or triple bond, e.g. 1-propenyl, 2- Butenyl, 4-pentenyl, 3-methyl-2-butenyl, 1-methyl-2-propenyl, 2-methyl, 2-propynyl, 2-propynyl, 2-butynyl, 4-pentynyl, 2-hexynyl, etc. and halo-lower alkynyl include 3-chloro-2-propenyl, 3-bromo-2-propenyl, 3, 3-dichloro-2-propenyl, 3-bromo-2-methyl -2-propenyl and the like.

여기서 싸이클로 알킬이란 용어는 3-7개의 탄소원자환을 가진 포화된 탄소환기를 의미하는데 예를들면 싸이클로프로필, 싸이클로부틸, 싸이클로펜틸, 싸이클로헥실, 2-메틸싸이클로부틸, 4-에틸 싸이클로 헥실등이다.The term cycloalkyl here means a saturated carbocyclic group having 3-7 carbon atom rings, for example cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, 2-methylcyclobutyl, 4-ethyl cyclohexyl, etc. .

여기서 저급알카노일이란 1-4개의 탄소수를 가진 포화된 지방족, 1가의 카복실산기인데 예를 들면 포르밀, 아세틸, 프로피오닐, 부티릴, 이소부티릴등이다.Lower alkanoyl is a saturated aliphatic, monovalent carboxylic acid group having 1-4 carbon atoms, for example, formyl, acetyl, propionyl, butyryl, isobutyryl and the like.

상기한 미국 특허에는 다음 구조식(Ia)의 1-R1-3-R5'CO-4aα-R3-5α-R4-6-R2"-7-R2-8-R2'-9-R"'2-1, 2, 3, 4, 4a 5, 10, 10a-옥타하이드로-2, 5-메타노벤조[g] 퀴놀린을 불활성 유기용매내에서 포름산이나 벤질-디-저급-알킬 암노늄 포르메이트나 트리-저급-알킬암모늄 포르메이트와 함께 가열하여 구조식(Ⅱ)의 화합물을 제조하는 방법에 대하여 기술되어 있다. 구조식(Ⅱa)의 목적화합물은 출발물질인 구조식(Ia)의 화합물을 (b)라고 표시한 부분에서 단절시켜 개환하므로써 제조된다. 그러나 이 방법은(a)로 표시한 부분이 단절되고 곧이어 R'5CO카보닐기가 질소원자에 다시 환화되므로 상당량의 구조식(ⅡI)의 1-R1-2-R5'-4aα-R3-5α-R4-6-R2"-7-R2-8-R2'-1, 2, 3, 4, 4a 5, 10, 10a-옥타하이드로-3, 5-에테노벤조[g] 퀴놀린이 제조되어 주생성물인 구조식(Ⅱa) 화합물의 수득률을 감소시킨다.The US patent 1-R 1 -3-R 5 'CO-4aα-R 3 -5α-R 4 -6-R 2 "-7-R 2 -8-R 2' in the following formula (Ia) - 9-R "' 2 -1, 2, 3, 4, 4a 5, 10, 10a-octahydro-2, 5-methanobenzo [g] quinoline in an inert organic solvent or formic acid or benzyl-di-lower- A method for preparing a compound of formula (II) by heating with alkyl ammonium formate or tri-lower-alkylammonium formate is described. The target compound of formula (IIa) is prepared by breaking the compound of formula (Ia), which is a starting material, at the portion indicated by (b) to ring-open. However, in this method, since the portion represented by (a) is disconnected and then the R ' 5 CO carbonyl group is cyclized to the nitrogen atom again, a considerable amount of 1-R 1-2 -R 5 ' -4aα-R 3 of formula (III) is used. -5α-R 4 -6-R 2 "-7-R 2 -8-R 2 '-1, 2, 3, 4, 4a 5, 10, 10a-octahydro-3, 5-ethenobenzo [g Quinoline is prepared to reduce the yield of the main product, Structural Formula (IIa).

두가지 반응식을 표시하면 다음과 같다.Two equations are shown below.

Figure kpo00003
Figure kpo00003

상기식에서 R1, R2, R'2, R"2, R3및 R4는 상술한 바와 같고 R5'는 수소, 저급알킬, 페닐 또는 페닐-저급-알킬이다.Wherein R 1 , R 2 , R ′ 2 , R ″ 2 , R 3 and R 4 are as described above and R 5 ′ is hydrogen, lower alkyl, phenyl or phenyl-lower-alkyl.

구조식(Ⅱ)화합물은 구조식(I)의 신규한 β-케토에스테르를 불활성 유기용매내에서 포름산이나 벤질-디-저급-알킬 암노늄 포르메이트나 트리-저급알킬 암모늄 포르메이트와 예컨대 120-150℃의 온도에서 가열시키면 구조식(ⅡI) 화합물의 부산물이 생성되지 않고 고수율로 제조될 수 있다. 반응은 구조식(I)화합물의 2-와 3-의 환의 탄소원자 사이에서 개환되고 곧바로 3-카보저급알콕시기, COOAIK가 탈 카브알콕실화되어 끝이 난다. 적당한 용매는 톨루엔, 크실렌, 메시틸렌이다. 특히 좋은 용매는 메시틸렌에 포름산을 넣은 것이고 특히 좋은 방법은 트리메틸 암모늄 포르메이트에서 개환하는 것이다.The compound of formula (II) may be prepared by incorporating the novel β-ketoester of formula (I) with formic acid or benzyl-di-lower-alkyl ammonium formate or tri-lower alkyl ammonium formate in an inert organic solvent such as 120-150 ° C. Heating at a temperature of does not produce by-products of the compound of formula IIl and can be prepared in high yield. The reaction is ring-opened between the carbon atoms of the 2- and 3- rings of the compound of formula (I), and ends immediately after the 3-carbo lower alkoxy group, COOAIK, is decarboxylated. Suitable solvents are toluene, xylene, mesitylene. A particularly good solvent is formic acid in mesitylene and a particularly good method is ring opening in trimethyl ammonium formate.

특히 선택적으로 R2, R2', R2" 및 R2"'중의 하나가 하이드록시인 구조식(Ⅱ)화합물은 상응하는 기가 저급알콕시인 상응하는 에테르로부터 그 에테르기를 브롬화 수소산의 수용액이나 소디움 프로필설파이드로 분해시켜 제조한다. 분해하기 위해 브롬화수소산 수용액을 사용할 때는 에테르 용액을 브롬화 수소산 수용액내에 환류시키고 반응혼합물로부터 직접 브롬화수소산염의 형태로 분리해 내거나 중성 용액으로 하여 유리염기 형태로 분리해낸다.In particular, the compound of formula (II) wherein optionally one of R 2 , R 2 ′, R 2 ″ and R 2 ″ is hydroxy has the ether group from the corresponding ether whose corresponding group is lower alkoxy, an aqueous solution or sodium profile of hydrobromic acid Prepared by decomposition with sulfides. When using an aqueous hydrobromic acid solution for decomposition, the ether solution is refluxed in the aqueous hydrobromic acid solution and separated directly from the reaction mixture in the form of hydrobromide or in neutral solution as a free base.

소디움 프로필설파이드가 사용될 때는 디메틸포름아미드 같은 불활성 유기 용매내에서 에테르 용액을 프로판티올을 소디움 하이드라이드에 가하여 제조된 소디움 프로필 설파이드 과량과 함께 환류시켜 수행된다.When sodium propyl sulfide is used, it is carried out by refluxing the ether solution in an inert organic solvent such as dimethylformamide with an excess of sodium propyl sulfide prepared by adding propanethiol to sodium hydride.

구조식(Ia)화합물보다 구조식(I) β-케토에스테르를 사용하는 더 좋은 잇점은 전자를 사용시의 반응시간은 며칠간, 어떤 때는 6일이나 걸리지만 구조식(I)의 β-케토에스테르를 사용시는 반응 시간이 몇 분내지 몇 시간이어서 대부분의 경우 용매로서 메시틸렌에 녹인 포름산을 사용할 때는 4-6시간만에 반응이 완결되고 145℃에서 트리메틸암모늄 포르메이트를 사용하면 9-13분안이 반응이 완결된다. 모든 경우에 반응이 진행됨에 따라 반응혼합물의 시료를 규칙적으로 박층크로마토그라피판에 놓고 반응시간이 경과함에 따라 출발물질이 없어지는 것을 기록한다.The advantage of using the structural formula (I) β-ketoester over the structural formula (Ia) is that the reaction time of the former takes several days and sometimes 6 days, but the reaction using the β-ketoester of structural formula (I) The reaction is completed in 4-6 hours when using formic acid dissolved in mesitylene as a solvent in most cases after several minutes to several hours, and in 9-13 minutes using trimethylammonium formate at 145 ° C. . In all cases, samples of the reaction mixture are regularly placed on a thin layer chromatography plate as the reaction proceeds and the starting material disappears as the reaction time elapses.

구조식(I)화합물은 구조식(Ib)의 1-R1-3-R5"CO-4aα-R3-5α-R4-6-R2"-7-R2-8-R2'-9-R"'2-1, 2, 3, 4, 4a 5, 10, 10a-옥타하이드로-2, 5-메타노벤조[g] 퀴놀린을 불활성 유기용매 내에서 예컨대 소드아마이드나 리티움 디이소프로필 아마이드 같은 알카리 금속 아마이드와 반응시키고 생성된 알카리 금속염을 적당한 아실할라이드 R5"'-CO-X 또는 저급알킬 할로포르메이트와 반응시켜 다음 반응순서에 따라 제조한다.The compound of formula (I) is represented by 1-R 1 --3-R 5 "CO-4aα-R 3 -5α-R 4 -6-R 2 " -7-R 2 -8-R 2 '-of formula (Ib). 9-R "' 2 -1, 2, 3, 4, 4a 5, 10, 10a-octahydro-2, 5-methanobenzo [g] quinoline in an inert organic solvent such as sodium amide or lithium diiso The reaction is carried out with an alkali metal amide such as propyl amide and the resulting alkali metal salt is reacted with a suitable acyl halide R 5 "'-CO-X or lower alkyl haloformate according to the following reaction sequence.

Figure kpo00004
Figure kpo00004

상기 식에서 R1, R2, R'2, R2", R2"', R3, R4및 AIK는 상술한 바와 같고 R"5및 R5"'는 R5"가 저급알콕시가 아닐 때 R5"'가 저급알콕시를 나타내는 것을 제외하고는 R5와 같고 X는 할로겐이고 M-N=B는 알카리금속(M) 아마이드(N=B)이다. 반응은 -10℃∼-70℃에서 잘 수행된다.Wherein R 1, R 2, R ' 2, R 2 ", R 2"', R 3, R 4 and AIK is the same as the above R "5 and R 5" 'is R 5 "is not a lower alkoxy Is the same as R 5 except that R 5 "'represents lower alkoxy, X is halogen and MN = B is an alkali metal (M) amide (N = B). The reaction is well performed at -10 ° C to -70 ° C.

적당한 용매로는 테트라하이드로푸란, 디에틸에테르 또는 디옥산이 있다. 출발물질인 구조식(Ib)화합물 및 그 제조방법은 미국 특허 3,932,422에 공지되어 있다.Suitable solvents are tetrahydrofuran, diethyl ether or dioxane. Structural (Ib) compounds as starting materials and methods for their preparation are known from US Pat. No. 3,932,422.

위에서 언급한 바와 같이 구조식(Ib) 화합물에서 3-아실기(COR5")와 구조식(I)β-케토에스테르에서 3-아실(R5CO) 및 3-카보-저급알콕시기(COOAIK)의 입체 구조는 확실히 밝혀지지 않았다. 그러나 구조식(Ⅱ)의 2, 6-메타노-3-벤즈아조신(구조식(I)의 β-케토에스테르로부터 제조됨)에 관한 한 구조식(I)화합물의 3위치에서의 입체구조에 대한 의문점은 토론의 여지가 있다. 왜냐하면 구조식(Ⅰ)화합물이 부재 위치인 3위치에서 파괴되어 구조식(Ⅱ) 화합물로 전환되기 때문이다. 3위치에서 2가지 입체 구조를 모두 가진 구조식(I) 화합물은 모두 구조식(Ⅱ) 화합물의 제조에 이용된다.As mentioned above, the 3-acyl group (COR 5 ″) in the formula (Ib) compound and the 3-acyl (R 5 CO) and 3-carbo-lower alkoxy group (COOAIK) in the formula (I) β-ketoester The steric structure is not clear, but as far as 2, 6-methano-3-benzazosine of formula (II) (prepared from β-ketoester of formula (I)) 3 of the compound of formula (I) The question of the steric structure at the position is debatable, because the compound of formula (I) is destroyed at position 3 and is converted to the compound of structure (II). All of the compounds having the structural formula (I) are used in the preparation of the structural formula (II) compounds.

구조식(Ib) 화합물을 아실화하거나 카복실화한 뒤 곧바로 개환하고 탈 카복실화하면 언제나 한가지의 깨끗한 구조식(Ⅱ) 화합물이 얻어진다.Acylation or carboxylation of the compound of formula (Ib) immediately after ring opening and decarboxylation results in one clean compound of formula (II).

본 발명 화합물은 구조화학적으로 이성체 즉 광학 이성체 및 기하이성체 상태로 존재할 수 있다. 원한다면 특별한 구조 화학적 형태를 분리하거나 생산해내는 것은 당분야에서 알려진 공지 방법에 따라 수행될 수 있다. 구조식(Ⅱ) 화합물의 명명시에 "ax"는 축성의(axial)를 의미하고 "eq"는 적도부근의(equat-orial)"를 의미하고 구조는 방향족환을 참조하여 그려졌다. 그리하여 구조식(Ⅱ)의 6(eq), 11(ax) 화합물은 cis 구조이고 6(eq), 11(eq) 화합물은 trans 구조이다.The compounds of the present invention may exist in structural isomers, ie optical isomers and geometric isomers. If desired, the separation or production of a particular structural chemical form can be carried out according to known methods known in the art. In naming compounds of formula II, "ax" means axial, "eq" means equi-orial, and the structure is drawn with reference to an aromatic ring. The 6 (eq) and 11 (ax) compounds of II) are cis structures and the 6 (eq) and 11 (eq) compounds are trans structures.

구조식(I), (Ia), (Ib), (Ic), 및 (ⅡI) 화합물의 명명법에서 구조는 방향족 수소환의 명명법에 준하고 "β"표시는 구조식(I)화합물의 2, 5-메타노 연결이나 구조식(ⅡI) 화합물의 3, 5-에테노연결에서 cis 구조를 나타낸다. 반대로 "α"표시는 같은 기에서 trans구조를 나타낸다.In the nomenclature of the compounds of formulas (I), (Ia), (Ib), (Ic), and (III), the structure follows the nomenclature of the aromatic hydrogen ring, and the "β" designation is 2, 5- of the compound of formula It shows cis structure in the 3, 5-etheno linkage of a metano linkage or a structural formula (III) compound. In contrast, the symbol "α" indicates trans structure in the same group.

본 발명 화합물의 구조는 합성 유형이나 원소 분석 및 적외나 핵자기공명 스펙트라에 의해 정해졌다.The structure of the compound of the present invention was determined by synthesis type or elemental analysis and infrared or nuclear magnetic resonance spectra.

반응진행사항이나 생성물의 동일성은 보통 박층 크로마토그라피에 의해 확인되었다.Reaction progress or product identity was usually confirmed by thin layer chromatography.

다음은 당업자가 본 발명을 실시하고 이용할 수 있도록 본 발명을수행하는 방법 및 공정과 가장 유리한 수행 방법을 기술한 것이다.The following describes methods and processes for carrying out the invention and the most advantageous methods of carrying out the invention to enable those skilled in the art to make and use the invention.

별도의 언급이 없는한 융점은 정확하지 못하다.Unless otherwise noted, the melting point is not accurate.

A. 구조식(I)의 저급알킬 3-R5CO-옥타하이드-2,5-메타노-벤조[g] 퀴놀린-3-카복실레이트의 제조.A. Preparation of lower alkyl 3-R 5 CO-octahydro-2,5-methano-benzo [g] quinoline-3-carboxylate of formula (I).

1. 상응하는 저급알킬 3-카볼실레이트의 아실화에 의한 방법.1. Process by acylation of the corresponding lower alkyl 3-carbosylate.

[실시예 1]Example 1

A. 헥산에 50ml(0.12몰)의 2, 4N n-부틸리티움을 녹인 용액에 0℃에서 약 30분간에 걸쳐 무수테트라 하이드로푸란 110ml에 녹인 13.1g(0.13몰)의 재증류한 디이소프로필아민 용액을 가했다.A. 13.1 g (0.13 mole) of redissolved in 110 ml of anhydrous tetrahydrofuran in a solution of 50 ml (0.12 mole) of 2,4N n-butyltium in hexane over 0 minutes at 0 ° C. An amine solution was added.

혼합물을 -60℃로 냉각시키고 테트라하이드로푸란 110ml에 녹인 34.3g(0.1몰)의 에틸-7-메톡시-1, 4aα, 5α-트리메틸-1, 2, 3, 4, 4a, 5, 10, 10a-옥타하이드로-2, 5-메타노벤조[g] 퀴놀린-3-카복실레이트 용액을 2시간 동안 가했다. 이 용액을 -60℃에서 약 30분간에 걸쳐 110ml의 테트라하이드로푸란에 녹인 18.8g(0.13몰)의 재증류한 헥사노일 클로라이드용액과 혼합하였다. 이 맑은 반응혼합액을 500ml의 중탄산나트륨 수용액에 가하고 100ml의 에테르로 두 번 추출하여 합하고 추출액을 소금물로 한번 씻고 황산나트륨상에서 건조시키고 증발시키면 44g의 유상물질이 얻어지고 이것을 방치하면 고체로 된다. 이 잔사를 헥산으로 재결정시키면 27.5g(63%)의 에틸-3-(1-옥소헥실)-7-메톡시-1, 4aα, 5α-트리메틸-1, 2, 3, 4, 4a, 5, 10, 10a-옥타하이드로-2, 5-메타노벤조[g] 퀴놀린-3-카복실레이트가 생성된다.The mixture was cooled to −60 ° C. and dissolved in 110 ml of tetrahydrofuran in 34.3 g (0.1 mol) of ethyl-7-methoxy-1, 4aα, 5α-trimethyl-1, 2, 3, 4, 4a, 5, 10, 10a-octahydro-2, 5-methanobenzo [g] quinoline-3-carboxylate solution was added for 2 hours. This solution was mixed with 18.8 g (0.13 mol) of redistilled hexanoyl chloride solution dissolved in 110 ml of tetrahydrofuran at -60 ° C. for about 30 minutes. The clear reaction mixture was added to 500 ml of sodium bicarbonate solution, extracted twice with 100 ml of ether, and the extract was washed once with brine, dried over sodium sulfate and evaporated to yield 44 g of oily substance which, when left to become a solid. The residue was recrystallized from hexane to give 27.5 g (63%) of ethyl-3- (1-oxohexyl) -7-methoxy-1, 4aα, 5α-trimethyl-1, 2, 3, 4, 4a, 5, 10, 10a-octahydro-2, 5-methanobenzo [g] quinoline-3-carboxylate is produced.

융점 117-120℃Melting point 117-120 ℃

위와 같은 방법으로 다음과 같은 구조식(I) 화합물도 마찬가지로 얻어졌다.In the same manner as above, the following structural formula (I) compound was also obtained.

B. 에틸 7-메톡시-1, 4aα, 5α-트리메틸-3-(4-메틸-1-옥소-펜틸)-1, 2, 2, 3, 4, 4a, 5, 10, 10a-옥타하이드로-2, 5-메타노벤조[g] 퀴놀린-3-카복실레이트(22.8g, 43%, 융점 97-100℃ 펜탄에서)는 40.5g(0.12몰)의 에틸 7-메톡시-1,4aα, 5α-트리메틸-1, 2, 3, 4, 4a, 5, 10, 10a-옥타하이드-2, 5-로메타노벤조[g] 퀴놀린-3-카복실레이트를 0.13몰의 리티움 디이소프로필 아마이드와 반응시키고 생성된 염을 17.5g(0.13몰)의 4-메틸펜타노일클로라이드와 반응시켜 제조했다.B. ethyl 7-methoxy-1, 4aα, 5α-trimethyl-3- (4-methyl-1-oxo-pentyl) -1, 2, 2, 3, 4, 4a, 5, 10, 10a-octahydro -2,5-methanobenzo [g] quinoline-3-carboxylate (22.8 g, 43%, at 97-100 ° C. pentane) has 40.5 g (0.12 mol) of ethyl 7-methoxy-1,4aα, 5α-trimethyl-1, 2, 3, 4, 4a, 5, 10, 10a-octahydro-2, 5-romethanobenzo [g] quinoline-3-carboxylate with 0.13 mole of lithium diisopropyl amide The resulting salt was prepared by reacting with 17.5 g (0.13 mol) of 4-methylpentanoyl chloride.

C. 에틸 7-메톡시-1, 5α-디메틸-3-(1-옥소펜틸)-1, 2, 3, 4, 4a, 5, 10, 10a-옥타하이드로-2, 5-메타노벤조[g] 퀴놀린-3-카복실레이트(5.2g, 27% 융점은 87-92℃ 펜탄에서)는 15.0g(0.046몰)의 에틸 7-메톡시-1, 5α-디메틸-1, 2, 3, 4, 4α, 5, 10, 10a-옥타하이드로-2, 5-메타노벤조[g] 퀴놀린-3-카복실레이트를 0.047몰의 리티움 디이소프로필아마이드와 반응시켜 제조했다.C. Ethyl 7-methoxy-1, 5α-dimethyl-3- (1-oxopentyl) -1, 2, 3, 4, 4a, 5, 10, 10a-octahydro-2, 5-methanobenzo [ g] Quinoline-3-carboxylate (5.2 g, 27% melting point at 87-92 ° C. pentane) is 15.0 g (0.046 moles) of ethyl 7-methoxy-1, 5α-dimethyl-1, 2, 3, 4 , 4α, 5, 10, 10a-octahydro-2, 5-methanobenzo [g] quinoline-3-carboxylate was prepared by reacting with 0.047 mole of lithium diisopropylamide.

상기한 실시예 1과 유사한 방법으로 다음표 1에 기술한 구조식(I) 화합물도 유사하게 제조된다. 융점과 재결정에 사용된 구분란에 융점(℃)/용매라고 표시한 것에 적혀있다.In a similar manner to Example 1 described above, the compound of formula (I) described in Table 1 was also prepared in a similar manner. In the section used for melting point and recrystallization, note the melting point (℃) / solvent.

[표 1]TABLE 1

Figure kpo00005
Figure kpo00005

Figure kpo00006
Figure kpo00006

Figure kpo00007
Figure kpo00007

Figure kpo00008
Figure kpo00008

Figure kpo00009
Figure kpo00009

2. 상응하는 3-카복실레이트나 3-R"5CO 케톤을 카복실화하여 제조하는 방법2. Method of carboxylation of the corresponding 3-carboxylate or 3-R " 5 CO ketone

[실시예 2]Example 2

A. 60ml의 테트라하이드로푸란에 0.055몰의 리티움 디이소프로필아마이드를 녹인 용액은 상기실시예 1에 기술한 방법대로 부틸리티움과 디이소프로필아민으로부터 제조되었다. 이렇게 생성된 용액을 -75℃로 냉각시키고 그 온도를 유지시키며 17.1g(0.05몰)의 에틸 7-메톡시-1,4aα, 5α-트리메틸-1, 2, 3, 4, 4a, 5, 10, 10a-옥타하이드로-2, 5-메타노벤조[g] 퀴놀린-3-카복실레이트와 약 30분에 걸쳐 혼합했다. 이 용액에 -75℃에서 한 시간 동안 80ml의 테트라하이드로푸란에 용해한 5.4g(0.05몰)의 에틸 클로로포메이트 용액을 가하고 혼합물을 1시간 동안 냉각시킨 다음 400ml의 중탄산나트륨 수용액에 붓고 실시예 1에서와 같은 방법으로 반응을 완결시키면 9.7g의 불순한 목적물이 생성되고 펜탄으로 재결정시키면 6.3g(30%)의 디에틸-7-메톡시-1, 4aα, 5α-트리메틸-1, 2, 3, 4, 4a, 5, 10a-옥타하이드로-2, 5-메타노벤조[g]퀴놀린-3, 3-디카복실레이트를 얻었다. 융점 89-91℃A. A solution of 0.055 mole of lithium diisopropylamide in 60 ml of tetrahydrofuran was prepared from butylrium and diisopropylamine according to the method described in Example 1 above. The resulting solution was cooled to -75 ° C. and maintained at a temperature of 17.1 g (0.05 mol) of ethyl 7-methoxy-1,4aα, 5α-trimethyl-1, 2, 3, 4, 4a, 5, 10 And 10a-octahydro-2 and 5-methanobenzo [g] quinoline-3-carboxylate over about 30 minutes. To this solution was added 5.4 g (0.05 mol) of ethyl chloroformate solution dissolved in 80 ml of tetrahydrofuran for 1 hour at -75 ° C, the mixture was cooled for 1 hour and then poured into 400 ml of sodium bicarbonate solution and in Example 1 Completion of the reaction in the same manner yields 9.7 g of impure target product, and recrystallization with pentane results in 6.3 g (30%) of diethyl-7-methoxy-1, 4aα, 5α-trimethyl-1, 2, 3, 4 , 4a, 5, 10a-octahydro-2, 5-methanobenzo [g] quinoline-3, 3-dicarboxylate was obtained. Melting point 89-91 ℃

위와 유사한 방법으로 구조식(Ib)의 적당한 3-R"5CO-1, 2, 3, 4, 4a, 5, 10, 10a-옥타하이드로-2, 5-메타노벤조[g] 퀴놀린과 에틸 클로로포르메이트를 디이소프로필아마이드 존재하에서 작용시켜 다음표 2와 같은 구조식(I) 화합물이 마찬가지로 제조된다.A similar 3-R " 5 CO-1, 2, 3, 4, 4a, 5, 10, 10a-octahydro-2, 5-methanobenzo [g] quinoline and ethyl chloro of the formula (Ib) The compound of formula (I) as shown in Table 2 is likewise prepared by acting formate in the presence of diisopropylamide.

[표 2]TABLE 2

Figure kpo00010
Figure kpo00010

Figure kpo00011
Figure kpo00011

Figure kpo00012
Figure kpo00012

Claims (1)

다음 구조식(Ib)화합물을 알카리금속 아마이드와 반응시키고 생성된 알카리금속염을 구조식 R5"-CO-X 화합물과 반응시켜 다음 구조식(I)의 메타노벤조[g] 퀴놀린-3-카복실레이트 화합물을 제조하는 방법.The following compound of formula (Ib) is reacted with an alkali metal amide and the resulting alkali metal salt is reacted with a compound of formula R 5 "-CO-X to give the metanobenzo [g] quinoline-3-carboxylate compound of formula (I) How to manufacture.
Figure kpo00013
Figure kpo00013
상기식에서In the above formula R1은 수소, 저급알킬, 저급알케닐, 저급알키닐, 할로-저급알케닐, 싸이클로알킬, 싸이클로알킬저급알킬, 2-또는 3-푸릴메틸, 또는 비치환된 환의 탄소원자에 1-3개의 메틸기로 치환된 2-또는 3-푸릴메틸 또는 페닐-저급알킬 또는 페닐환에 할로겐, 저급알킬, 하이드록시, 저급알카노일옥시, 저급알콕시, 저급알킬메르캅토, 트리플루오로메틸, 아미노, 저급알카노일아미노나 인접탄소원자에 붙은 하나의 메틸렌 디옥시 중 1-2개로 치환된 페닐-저급알킬기이고, R2, R'2, R2" 및 R2"'는 모두 수소이거나, 또는 그중 3개는 수소이고 나머지 하나는 할로겐, 저급알킬, 하이드록시, 저급알카노일옥시, 저급알콕시, 저급알킬메르캅토, 트리플루오로메틸, 니트로, 아미노, 저급알카노일아미노, 저급알콕시카보닐아미노, 페닐이거나 또는 인접한 2개가 함께 메틸렌디옥시이고;R 1 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl, halo-low alkenyl, cycloalkyl, cycloalkyl lower alkyl, 2- or 3-furylmethyl, or 1-3 carbon atoms in unsubstituted ring Halogen, lower alkyl, hydroxy, lower alkanoyloxy, lower alkoxy, lower alkyl mercapto, trifluoromethyl, amino, lower alka to 2- or 3-furylmethyl or phenyl-lower alkyl or phenyl rings substituted with methyl groups A phenyl-lower alkyl group substituted with 1-2 of one methylene dioxy attached to a noylamino or adjacent carbon atom, and R 2 , R ' 2 , R 2 "and R 2 "' are all hydrogen or three of them Is hydrogen and the other is halogen, lower alkyl, hydroxy, lower alkanoyloxy, lower alkoxy, lower alkyl mercapto, trifluoromethyl, nitro, amino, lower alkanoylamino, lower alkoxycarbonylamino, phenyl or Two adjacent together methylenedi And when; R3는 수소 또는 저급알킬이고;R 3 is hydrogen or lower alkyl; R4는 수소, 저급알킬 ,저급알콕시-저급알킬, 하이드록시저급알킬, 저급알킬티오-저급알킬, 저급알킬, 설피닐-저급알킬, 페닐티오-저급알킬, 페닐-설피닐-저급알킬, 저급알케닐 또는 할로저급알킬이거나, R3와 R4가 함께 2가의 저급알킬렌-(CH2)n-(여기서 n은 3이나 4의 정수임)이고;R 4 is hydrogen, lower alkyl, lower alkoxy-lower alkyl, hydroxy lower alkyl, lower alkylthio-lower alkyl, lower alkyl, sulfinyl-lower alkyl, phenylthio-lower alkyl, phenyl-sulfinyl-lower alkyl, lower Alkenyl or haloloweralkyl, or R 3 and R 4 together are divalent loweralkylene- (CH 2 ) n—, where n is an integer of 3 or 4; R5는 저급알킬, 저급알킬티오-저급알킬, 저급알콕시-저급알킬, 저급알콕시, 싸이클로알킬, 사이클로알킬-저급알킬, 2-또는 3-푸릴, 2-또는 3-푸릴-(CH2)m (여기서, m은 2-4의 정수임), 또는 비치환, 된환의 탄소원자가 1-3개의 메틸기로 치환된 2-또는 3-프릴이나 2-또는 3-푸릴-(CH2)m, 또는 페닐 페닐-(CH2)m, 또는 페닐환에 할로겐, 저급알킬, 하이드록시, 저급알카노일옥시, 저급알콕시, 저급알킬메르캅토, 트리플루오로메틸, 아미노, 저급알카노일아미노 또는 인접탄소원자에 붙은 하나의 메틸렌디옥시기중 1-2개로 치환된 페닐이나 페닐-(CH2)m이고;R 5 is lower alkyl, lower alkylthio-lower alkyl, lower alkoxy-lower alkyl, lower alkoxy, cycloalkyl, cycloalkyl-lower alkyl, 2- or 3-furyl, 2- or 3-furyl- (CH 2 ) m (Where m is an integer of 2-4), or unsubstituted, 2- or 3-pril or 2- or 3-furyl- (CH 2 ) m, or phenyl, in which a substituted carbon atom is substituted with 1-3 methyl groups Phenyl- (CH 2 ) m or a phenyl ring attached to halogen, lower alkyl, hydroxy, lower alkanoyloxy, lower alkoxy, lower alkyl mercapto, trifluoromethyl, amino, lower alkanoylamino or adjacent carbon atoms Phenyl substituted with 1-2 of one methylenedioxy group or phenyl- (CH 2 ) m; Alk는 저급알킬이고;Alk is lower alkyl; R"5및 R"'5는 R5와 같고 (단, R5"가 저급알콕시가 아닐 때 R5"'는 저급알콕시기이어야한다);R "5 and R"'5 and R 5 are the same (however, "time is not a lower alkoxy R 5' R 5 'is to be a lower alkoxy group); X는 할로겐이다.X is halogen.
KR1019810003793A 1978-03-23 1981-10-07 Process for preparing methanobenzo(g)quinoline-3-carboxylate KR820000254B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019810003793A KR820000254B1 (en) 1978-03-23 1981-10-07 Process for preparing methanobenzo(g)quinoline-3-carboxylate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR7800801A KR820000253B1 (en) 1978-03-23 1978-03-23 Process for preparing benzazocines
KR1019810003793A KR820000254B1 (en) 1978-03-23 1981-10-07 Process for preparing methanobenzo(g)quinoline-3-carboxylate

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR7800801A Division KR820000253B1 (en) 1978-03-23 1978-03-23 Process for preparing benzazocines

Publications (1)

Publication Number Publication Date
KR820000254B1 true KR820000254B1 (en) 1982-03-10

Family

ID=26626161

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810003793A KR820000254B1 (en) 1978-03-23 1981-10-07 Process for preparing methanobenzo(g)quinoline-3-carboxylate

Country Status (1)

Country Link
KR (1) KR820000254B1 (en)

Similar Documents

Publication Publication Date Title
US4146718A (en) Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
CZ85293A3 (en) Process for preparing pyrimidine compounds
JP2004522744A (en) Clopidogrel manufacturing method
US4178463A (en) Process for making 4-aminohex-5-enoic acid
SU719499A3 (en) Method of preparing 1,2,3,4,6,7-hexahydro-11 b alpha-h-benzo(alpha)-quinolysin derivatives or their salts
AU670454B2 (en) Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid
BG98817A (en) Method for the preparation of flunixin and its intermediate compounds
KR820000254B1 (en) Process for preparing methanobenzo(g)quinoline-3-carboxylate
FI78084B (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA, TERAPEUTISKT VERKSAMMA BENSOPYRANDERIVAT.
US7423152B2 (en) Process for the manufacture of intermediates in camptothecin production
CA1129413A (en) Tetrahydrothiopyrano ¬2,3-b| indole derivatives
Fieser et al. An improved method for the synthetic preparation of methylcholanthrene
KR820000253B1 (en) Process for preparing benzazocines
CA2061311A1 (en) New phenylethanolamino- and phenylethanolaminomethyltetralines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
Nalliah et al. A versatile synthesis of spirobenzylisoquinoline and phthalideisoquinoline alkaloids. Conversion of a phthalideisoquinoline to spirobenzylisoquinolines
US4228285A (en) 14-Hydroxy-6-oxamorphinans and 14-hydroxy-6-oxaisomorphinans
US6414180B1 (en) Synthesis of chiral β-amino acids
US4235778A (en) 2-Pyrrolidone compounds and processes for making same
US3904633A (en) Lysergic amides
JPS649316B2 (en)
CA1095905A (en) 2,5-methanobenzo¬g| quinoline-3-carboxylate esters
Jian et al. Facile preparation of some highly hindered chiral 1, 2-diphenyl-2-(N-monoalkyl) amino alcohols and N-benzylbornamine
EP1207153A1 (en) Process for the preparation of indole derivatives or salts thereof
US4727149A (en) Preparation of nitriles of fused ring pyridine derivatives
JPS60142963A (en) 2,6-methano-3-benzoazocine derivative and manufacture